Innovative Methods for Rare Disease Drug Development (Chapman & Hall/CRC Biostatistics Series) - Image 1

£115.22

CRC Press Innovative Methods for Rare Disease Drug Development (Chapman & Hall/CRC Biostatistics Series)

Name: Innovative Methods for Rare Disease Drug Development (Chapman & Hall/CRC Biostatistics Series)
Brand: CRC Press
Price: 115.22 GBP
Availability: InStock

Pharmacy - Dispensing

Price History & Forecast

Last 31 days • 31 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 31 days • 1 price levels

Days at Price

Price Analysis

Most common price: £115 (31 days, 100.0%)

Price range: £115 - £115

Price levels: 1 different prices over 31 days

Description

Product Description In the United States, a rare disease is defined by the Orphan Drug Act as a disorder or condition that affects fewer than 200,000 persons. For the approval of "orphan" drug products for rare diseases, the traditional approach of power analysis for sample size calculation is not feasible because there are only limited number of subjects available for clinical trials. In this case, innovative approaches are needed for providing substantial evidence meeting the same standards for statistical assurance as drugs used to treat common conditions. Innovative Methods for Rare Disease Drug Development focuses on biostatistical applications in terms of design and analysis in pharmaceutical research and development from both regulatory and scientific (statistical) perspectives. Key Features: Reviews critical issues (e.g., endpoint/margin selection, sample size requirements, and complex innovative design). Provides better understanding of statistical concepts and methods which may be used in regulatory review and approval. Clarifies controversial statistical issues in regulatory review and approval accurately and reliably. Makes recommendations to evaluate rare diseases regulatory submissions. Proposes innovative study designs and statistical methods for rare diseases drug development, including n-of-1 trial design, adaptive trial design, and master protocols like platform trials. Provides insight regarding current regulatory guidance on rare diseases drug development like gene therapy. About the Author Shein-Chung Chow, Ph.D. is currently a Professor at Duke University School of Medicine, Durham, NC. He was previously the Associate Director at the Office of Biostatistics, Center for Drug Evaluation and Research, United States Food and Drug Administration (FDA). Dr. Chow has also held various positions in the pharmaceutical industry such as Vice President at Millennium, Cambridge, MA, Executive Director at Covance, Princeton, NJ, and Director and Department Head at Bristol-Myers Squibb, Plainsboro, NJ. He was elected Fellow of the American Statistical Association and an elected member of the ISI (International Statistical Institute). Dr. Chow is Editor-in-Chief of the Journal of Biopharmaceutical Statistics and Biostatistics Book Series, Chapman and Hall/CRC Press, Taylor & Francis, New York. Dr. Chow is the author or co-author of over 300 methodology papers and 30 books.

Product Specifications

Brand: CRC Press
Format: Hardcover
ASIN: 0367502100
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 12 November 2020
Listed Since: 22 May 2020

Barcode

No barcode data available

CRC Press Innovative Methods for Rare Disease Drug Development (Chapman & Hall/CRC Biostatistics Series)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)

Encyclopedia of Biopharmaceutical Statistics - Four Volume Set

Quantitative Methods for Traditional Chinese Medicine Development: 83 (Chapman & Hall/CRC Biostatistics)

Quantitative Methods for Traditional Chinese Medicine Development (Chapman & Hall/Crc Biostatistics)

Analytical Similarity Assessment in Biosimilar Product Development

Methodologies in Biosimilar Product Development (Chapman & Hall/CRC Biostatistics Series)

Case Studies in Innovative Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Drug Development for Rare Diseases (Chapman & Hall/CRC Biostatistics Series)

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

Phase II Clinical Development of New Drugs (ICSA Book Series in Statistics)

Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)

Statistical Methods in Drug Combination Studies: 69 (Chapman & Hall/CRC Biostatistics Series)

Statistical Remedies for Medical Researchers (Springer Series in Pharmaceutical Statistics)

Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Contemporary Biostatistics with Biopharmaceutical Applications (ICSA Book Series in Statistics)

Bayesian Methods in Pharmaceutical Research (Chapman & Hall/CRC Biostatistics Series)

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

CRC Press Statistical Approaches in Oncology Clinical Development

Statistical Approaches in Oncology Clinical Development: Current Paradigm and Methodological Advancement (Chapman & Hall/CRC Biostatistics Series)

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Multiple Testing Problems in Pharmaceutical Statistics: 33 (Chapman & Hall/CRC Biostatistics Series)